Last week it was announced that the German firm TVM Capital will manage a Montréal fund dedicated to the life sciences sector and meant to allow the multinational pharmaceutical Eli Lilly, amongst others, to set up shop in Québec’s metropolis.
With $150M planned investments, does this mean that Québec’s industrial policy regarding biotech has suddenly been brought back to life? No, actually, it doesn’t.
On the contrary, the time has come to assess how effective policies regarding the pharmaceutical industry are. For some twenty years, Québec has put everything in place to attract giants of this powerful industry. The aim was obviously to take advantage of the spillovers regarding investments, research, employment, etc. ...Read more
Tags: big business·big pharma·Health Care·Pharmacare·spillovers·subsidies
In August Canadian Business magazine published my article on why inequality is bad for business. It is produced in full below.
Last week the International Monetary Fund, not known for left-leaning views, released a series of articles entitled “Why Inequality Throws Us Off Balance”.
One of the papers is by Andrew Berg and Jonathan Ostry entitled “Equality and Efficiency: Is there a trade-off or do the two go hand in hand? A few months earlier they had written a provocative piece “Inequality and Unsustainable Growth” documenting how lower inequality is linked to more sustained periods of growth….and that higher inequality means more volatility. ...Read more
Tags: big business·Conference Board of Canada·IMF